| Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a … A Zanchetti, MG Bond, M Hennig, A Neiss, G Mancia, C Dal Palù, ... Circulation 106 (19), 2422-2427, 2002 | 873 | 2002 |
| Relation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA) G Mancia, G Parati, M Hennig, B Flatau, S Omboni, F Glavina, B Costa, ... Journal of hypertension 19 (11), 1981-1989, 2001 | 543 | 2001 |
| Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis A Zanchetti, MG Bond, M Hennig, A Neiss, G Mancia, C Dal Palù, ... Journal of hypertension 16 (7), 949-961, 1998 | 373 | 1998 |
| Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima–media thickness: the European Lacidipine Study on Atherosclerosis (ELSA) R Tang, M Hennig, B Thomasson, R Scherz, R Ravinetto, R Catalini, ... Journal of hypertension 18 (2), 197-201, 2000 | 223 | 2000 |
| Baseline values but not treatment-induced changes in carotid intima-media thickness predict incident cardiovascular events in treated hypertensive patients: findings in the … A Zanchetti, M Hennig, R Hollweck, G Bond, R Tang, C Cuspidi, G Parati, ... Circulation 120 (12), 1084-1090, 2009 | 209 | 2009 |
| The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial MK Steuer-Vogt, V Bonkowsky, P Ambrosch, M Scholz, A Neiβ, J Strutz, ... European journal of cancer 37 (1), 23-31, 2001 | 202 | 2001 |
| Effectiveness of theophylline prophylaxis of renal impairment after coronary angiography in patients with chronic renal insufficiency W Huber, C Schipek, K Ilgmann, M Page, M Hennig, A Wacker, ... The American journal of cardiology 91 (10), 1157-1162, 2003 | 160 | 2003 |
| Cardiac output determination in children: equivalence of the transpulmonary thermodilution method to the direct Fick principle C Pauli, U Fakler, T Genz, M Hennig, HP Lorenz, J Hess Intensive care medicine 28, 947-952, 2002 | 147 | 2002 |
| Effect of a milk drink supplemented with whey peptides on blood pressure in patients with mild hypertension YM Lee, T Skurk, M Hennig, H Hauner European Journal of Nutrition 46, 21-27, 2007 | 137 | 2007 |
| Assessment of long-term antihypertensive treatment by clinic and ambulatory blood pressure: data from the European Lacidipine Study on Atherosclerosis G Mancia, G Parati, G Bilo, A Maronati, S Omboni, H Baurecht, M Hennig, ... Journal of hypertension 25 (5), 1087-1094, 2007 | 127 | 2007 |
| Immunomonitoring results of a phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM× anti-CD3) M Jäger, A Schoberth, P Ruf, J Hess, M Hennig, B Schmalfeldt, ... Cancer Research 72 (1), 24-32, 2012 | 123 | 2012 |
| Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer F Lordick, S Lorenzen, J Stollfuss, U Vehling-Kaiser, F Kullmann, ... British journal of cancer 93 (2), 190-194, 2005 | 121 | 2005 |
| Prevalence and incidence of the metabolic syndrome in the European Lacidipine Study on Atherosclerosis (ELSA) and its relation with carotid intima–media thickness A Zanchetti, M Hennig, H Baurecht, R Tang, C Cuspidi, S Carugo, ... Journal of hypertension 25 (12), 2463-2470, 2007 | 120 | 2007 |
| Cardiac index monitoring by pulse contour analysis and thermodilution after pediatric cardiac surgery U Fakler, C Pauli, G Balling, HP Lorenz, A Eicken, M Hennig, J Hess The Journal of thoracic and cardiovascular surgery 133 (1), 224-228, 2007 | 102 | 2007 |
| Phase II trial of irinotecan plus docetaxel in cisplatin-pretreated relapsed or refractory oesophageal cancer F Lordick, C Von Schilling, H Bernhard, M Hennig, R Bredenkamp, ... British journal of cancer 89 (4), 630-633, 2003 | 99 | 2003 |
| Humoral response to catumaxomab correlates with clinical outcome: results of the pivotal phase II/III study in patients with malignant ascites MG Ott, F Marmé, G Moldenhauer, H Lindhofer, M Hennig, R Spannagl, ... International journal of cancer 130 (9), 2195-2203, 2012 | 94 | 2012 |
| Capecitabine plus docetaxel every 3 weeks in first-and second-line metastatic oesophageal cancer: final results of a phase II trial S Lorenzen, J Duyster, C Lersch, S von Delius, M Hennig, R Bredenkamp, ... British journal of cancer 92 (12), 2129-2133, 2005 | 94 | 2005 |
| Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial MA Ströhlein, F Lordick, D Rüttinger, KU Grützner, OC Schemanski, ... Oncology Research and Treatment 34 (3), 101-108, 2011 | 86 | 2011 |
| Ultrasound screening for internal jugular vein thrombosis aids the detection of central venous catheter‐related infections in patients with haemato‐oncological diseases: a … F Lordick, M Hentrich, T Decker, M Hennig, H Pohlmann, R Hartenstein, ... British journal of haematology 120 (6), 1073-1078, 2003 | 85 | 2003 |
| Assumed oxygen consumption frequently results in large errors in the determination of cardiac output U Fakler, C Pauli, M Hennig, W Sebening, J Hess The Journal of thoracic and cardiovascular surgery 130 (2), 272-276, 2005 | 81 | 2005 |
